Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05332561 |
| Consolidated Lead Sponsor | German Cancer Research Center |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 240 participants (ESTIMATED) |
| Registered Start Date | 2023-06-29 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Universitätsklinikum Tübingen | Tübingen, Germany | Open Hospital Dossier -> |
| Universitätsklinikum Ulm | Ulm, Germany | Open Hospital Dossier -> |
| Charité Universitätsmedizin Berlin | Berlin, Germany | Open Hospital Dossier -> |
| Universitätsklinikum Essen | Essen, Germany | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.